HTLV-1 Letter

ABOUT HTLV-1 LETTER Time to eradicate HTLV-1: an open letter to WHO 10, May 2018 **Summary version of this letter published Lancet here. On behalf of Human T Cell Leukemia Virus-1 (HTLV-1) positive patients, expert clinicians and scientists working in the field of HTLV-1 clinical and laboratory research. Dear Dr. Tedros Ghebreyesus, We are writing…

Read More

HTLV-1 TASK FORCE

ABOUT THE HTLV-1 TASK FORCE HTLV WORLD DAY –  NOVEMBER 10TH – CLICK HERE TO LEARN MORE ABOUT THE TASK FORCE The Global Virus Network (GVN) formed an international Task Force on Human T-Leukemia Virus (HTLV-1), the world’s first known human retrovirus and the only known leukemia-causing virus. Experts from 11 countries, led by Dr. Robert Gallo, GVN co-founder…

Read More

Global Virus Network (GVN) Catalyzes World Health Organization (WHO) to Officially Recognize HTLV-1 as Threatening Pathogen to Humans

March 29, 2021 During GVN’s 9th International Meeting in Melbourne, Australia on September 25-27, 2017 in partnership with the Peter Doherty Institute and the Institut Pasteur, researchers held impressive sessions on one of the most potent human carcinogens, human T cell leukemia virus-1 (HTLV-1).  The sessions were organized by Dr. Sharon Lewin, Director of The…

Read More

Time to eradicate HTLV-1: an open letter to WHO

Time to eradicate HTLV-1: an open letter to WHO 10, May 2018 **Summary version of this letter published Lancet here. On behalf of Human T Cell Leukemia Virus-1 (HTLV-1) positive patients, expert clinicians and scientists working in the field of HTLV-1 clinical and laboratory research. Dear Dr. Tedros Ghebreyesus, We are writing to you today…

Read More

Deadly, But Largely Unknown: GVN Spurs Efforts to Combat HTLV-1

Deadly, But Largely Unknown: GVN Spurs Efforts to Combat HTLV-1 Thirty-eight years ago, Dr. Robert Gallo and his colleagues discovered Human T-cell Leukemia Virus 1 (HTLV-1), the first known human retrovirus and the first virus shown to cause cancer. This breakthrough is perhaps best known because it led another momentous discovery, the identification of HIV.…

Read More

HTLV-1 Task Force

HTLV-1 Task Force HTLV world day –  November 10th – click here to learn more About The Task Force The Global Virus Network (GVN) formed an international Task Force on Human T-Leukemia Virus (HTLV-1), the world’s first known human retrovirus and the only known leukemia-causing virus. Experts from 11 countries, led by Dr. Robert Gallo,…

Read More

Forefront of Virology Webinar Featuring Dr. Eduardo Gotuzzo

WELCOME TO Dr. Eduardo Gotuzzo – June 25, 2024 – “HTLV-1 Is also a Sexually Transmitted Infection: New Insights on an Endemic, Oncogenic Virus” Eduardo Gotuzzo, MD FACP FIDSA FESCMID Emeritus Professor Universidad Peruana Cayetano Heredia Instituto de Medicina Tropical “Alexander von Humboldt” Dr. Gotuzzo is Emeritus Professor, Former Director of the Instituto de Medicina…

Read More

Internationally Renowned Public Health Expert Sten Vermund Appointed GVN President

Brings Decades Of Infectious Disease Epidemiology & Prevention Experience Enhancing GVN’s Abilities To End Viral Threats & Advance Pandemic Preparedness Dr. Sten Vermund co-leads discussions at GVN’s annual meeting held last month in Monte Carlo, Monaco. Credit: Claudia G. Albuquerque Baltimore, MD, November 2, 2023:  The Global Virus Network (GVN) today announced the appointment of…

Read More

Forefront Of Virology Webinars

What We Do > Training and Education > Webinars Forefront of Virology Webinars The Global Virus Network hosts a webinar series for virus knowledge-sharing, featuring expert virologists including from GVN Centers of Excellence around the world. The topics range from the COVID-19 pandemic and other human viral threats to the latest scientific progress in virology.…

Read More

Action Committees

What We Do > Action Committees Action Committees Action Committees (formerly Task Forces and Watch Groups) is a key activity of the Global Virus Network. There are two types: Formed in response to a specific virus outbreak, epidemic, or pandemic. Focused on seven highly pathogenic virus categories and emerging pathogens: respiratory, retroviruses, oncogenic, arbovirology, hemorrhagic…

Read More